Spotting Predatory Journals: A Practical Checklist

Oct 5, 2026

Last March I got an email at 11:40 on a Sunday night from a third-year PhD student I'd examined the year before. Subject line: "Have I ruined my career?" She'd submitted a chapter of her thesis to a journal that had emailed her directly, praising her "esteemed contribution to the field." Acceptance came back in six days with no reviewer comments, just a formatted PDF and an invoice for $1,490. She'd already paid.

I wrote back the next morning with three questions, and I'll give you the same three before anything else, because they catch most cases in under five minutes:

  1. Did they contact you first, by email, unsolicited?

  2. Can you find the journal's content in a database you'd actually use to find papers for your own literature review?

  3. Did anyone ask you to change anything?

Her answers were yes, no, and no. That's the pattern.

What "predatory" actually means, and why the label is slippery

People use "predatory" to mean "a journal that takes your money and doesn't do peer review." That's the core of it. But in practice you're looking at a spectrum, not a binary, and I think most advice gets this wrong by implying there's a clean list of good journals and bad ones.

At one end: outright fraud. Hijacked journal titles, fake impact factors, editorial boards full of people who've never heard of the journal. At the other end: small, under-resourced, genuinely well-meaning journals with sloppy websites and thin peer review. In the middle there's a large grey zone of publishers that do something resembling review but would publish almost anything.

Why does the distinction matter? Because your hiring committee, your funder and your promotion panel don't care about your intentions. They care about whether the venue signals quality. I've sat on panels where a CV with four papers in obvious mills did more damage than having no papers at all. It reads as poor judgment, and judgment is most of what we're assessing.

So I don't ask "is this journal predatory?" I ask "would I be comfortable listing this in a grant application I was defending in front of a skeptical reviewer?" That question is much easier to answer honestly.

The red flags that actually predict trouble

I've looked at hundreds of these over the years, usually because a colleague forwarded me an email asking "is this real?" Here's what consistently separates the mills from the legitimate-but-obscure.

Flattery in the solicitation email

Real journals rarely cold-email individual researchers asking for manuscripts. When they do, it's usually a named editor inviting a specific piece, referencing specific work. The mill version reads like this:

Dear Esteemed Dr. [Name], We have read your remarkable article and are highly impressed by your profound research. We cordially invite you to submit any manuscript to our prestigious journal. Rapid publication within 7 days guaranteed.

Note the tells: generic praise, no reference to the actual content of your paper, "any manuscript," and a publication speed promise. Also: the scope. One of my postdocs, who works on cardiac imaging, got an invitation from something calling itself an "International Journal of Medicine, Engineering and Social Sciences." No real journal covers that range.

Speed promises

Legitimate peer review in most fields takes four to twelve weeks minimum for a first decision. There are fast journals — some of the big open-access megajournals turn things around in three or four weeks — but nobody credible guarantees acceptance within a week, because that would mean the decision is made before review.

A six-day acceptance with zero reviewer comments isn't fast peer review. It's no peer review.

Fees that appear late

Open access APCs are normal and fine. What's not normal is discovering the fee after acceptance. Legitimate journals publish their APC on the website, usually on the author guidelines page, before you submit. If you had to hunt for it, or if it only showed up on the invoice, that's a deliberate design choice.

Watch also for "withdrawal fees." I know a clinician who tried to pull a paper after realizing what he'd submitted to and was told it would cost him $600. That's not a journal policy; that's a hostage situation.

Metrics that don't exist

"Global Impact Factor," "Universal Impact Factor," "Index Copernicus Value 6.42," "Scientific Journal Impact Factor." These are invented or pay-to-list metrics designed to look like Clarivate's Journal Impact Factor. If a journal is leading with a metric you've never seen in your own field, go look it up. It takes thirty seconds and the result is usually a website that will sell you an impact factor too.

Website and contact details

Look for: a physical address that resolves to a residential building or a mail drop, a Gmail or Yahoo address for the editorial office, broken English in the formal policy pages (not just the odd typo — whole sections that read as if machine-translated), and missing or copy-pasted ethics statements. I once found identical "publication ethics" text across four supposedly unrelated publishers, all lifted word for word from a legitimate publisher's page.

How to verify indexing properly

This is where people get lazy, and it's the single most useful check you can do.

Journals love to list "indexed in" on their homepage. Google Scholar, ResearchGate, Academia.edu, CrossRef and "Index Copernicus" are not meaningful indexing. Google Scholar indexes almost anything with a web page. CrossRef is a DOI registry — anyone who pays can register DOIs.

What counts is selective indexing with editorial screening. Here's the sequence I use:

  1. Search the journal name in PubMed (for biomedical work) and see whether articles come up. You can check a journal directly with a query like a journal-field PubMed search — swap in the title you're checking. If nothing comes back, it isn't MEDLINE or PubMed Central indexed, whatever the website claims. Note that PMC deposit alone, which some mills arrange through funder mandates, isn't the same as MEDLINE selection.

  2. Check Web of Science and Scopus through your library. Both publish their source lists. "Emerging Sources Citation Index" is real but much less selective than SCIE or SSCI — worth knowing the difference.

  3. If it's open access, check DOAJ. DOAJ removed thousands of journals in a re-application exercise years ago specifically to clear out the junk, and its criteria now cover editorial process transparency, licensing and APC disclosure. DOAJ listing isn't a guarantee of quality, but absence from DOAJ for a journal that claims to be a flagship open-access title is a question worth asking.

  4. Check your field's own database. PsycINFO, EconLit, ERIC, CAB Abstracts, SciELO. Field-specific curation is often stricter than the general ones.

Then do the reverse test, which almost nobody does and which I find more revealing than any of the above: open the journal's most recent issue and read three abstracts. Are they in the stated scope? Are they competent? Would you cite any of them? I had a mentee check a journal this way and find a paper on supply chain logistics in what was supposedly a nephrology journal. Decision made.

Checking the editorial board (the part people skip)

A board of real, senior names is the easiest thing in the world to fake, because mills simply scrape names from conference programs.

Pick two or three board members — ideally ones at institutions you can reach — and verify independently:

  • Does the person's own university page or ORCID record mention this editorial role? Academics list editorships. They're prestige items.

  • Are the affiliations current? Mills often list people at institutions they left years ago, or who have died.

  • Is there an editor-in-chief with a named email at an institutional domain, or just "editor@journalname.com"?

If you can't resolve it, email one of them. I've done this maybe a dozen times and the responses fall into two groups: a friendly "yes, I handle submissions in X area," or a startled "I have no idea why my name is on that site, please tell me where you found it." Both answers are useful.

The ten-minute checklist

Run this before you submit anywhere you haven't published before. I keep a version of it in a note on my phone.

  • Did they solicit me, or did I choose them?

  • Can I find their articles in PubMed, Scopus, Web of Science or my field's main database?

  • Is the APC stated clearly on the website before submission?

  • Does the editor-in-chief exist, with an institutional email and a verifiable role?

  • Do two board members confirm, or at least list, the role publicly?

  • Is the scope coherent and narrow enough to be real?

  • Are the three most recent articles something I'd be happy to appear alongside?

  • Is there a real archiving arrangement (CLOCKSS, Portico, PMC) so the content survives if the publisher folds?

  • Does the journal follow recognized standards — ICMJE authorship criteria, COPE membership, EQUATOR Network reporting guidelines such as PRISMA for reviews and CONSORT for trials — and does it actually enforce them in published papers?

  • Would I defend this choice out loud to a promotion panel?

Two "no" answers is enough to walk away. One "no" is enough to ask someone senior. And Think. Check. Submit. exists precisely for this — it's short, free, and I send it to students more often than any other link.

The enforcement point in item nine matters more than the claim. Lots of mills display a COPE logo they're not entitled to. Check the member directory on COPE's own site rather than trusting the badge. Similarly, a journal that says it requires PRISMA but publishes systematic reviews with no flow diagram and no protocol registration is telling you what its review process is really like.

If you've already submitted

This is the part of the conversation where people panic, and panic produces worse decisions than the original mistake. Here's the order I'd work through.

If it isn't published yet

Withdraw in writing, immediately, and keep the email. Something like:

Dear Editor, I am withdrawing manuscript [reference number] from consideration, effective today. I have not signed a copyright transfer or license agreement and no article processing charge has been paid. Please confirm in writing that the manuscript has been removed from your system and that it will not be published. I will not be submitting elsewhere until I have your confirmation.

Don't negotiate. Don't apologize. If they demand a withdrawal fee you never agreed to, say that no such fee appears in the terms you accepted, and send a copy of your email to your institution's research office. In several cases I've seen, that's where it ends — mills don't want attention.

Do not submit elsewhere until you have confirmation, or at minimum a documented paper trail showing a reasonable withdrawal attempt and a deadline you gave them. Simultaneous submission is a real ethics breach and you don't want to swap one problem for another.

If it's already published

Harder, and I'll be honest about the trade-off. Formally requesting retraction from a mill often goes nowhere; they have no retraction process. You usually can't republish the same work elsewhere, because it's technically in the public record and most journals will treat it as duplicate publication.

What I'd do:

  • Write once, requesting removal, with a deadline. Keep the correspondence.

  • Tell your supervisor, department head or research integrity office before they find out another way. I've never seen this go badly for an early-career researcher who came forward. I have seen it go badly for people who hid it.

  • Decide deliberately whether to list it on your CV. My view: list it. A gap that a committee discovers is worse than a line they can ask about. If it comes up, you say you were targeted early in your career, you learned how to verify a venue, and here's your checklist. That answer lands well.

  • If the work is genuinely novel and important, talk to an editor at a real journal before doing anything else. Some will consider substantially extended and reanalyzed work with full disclosure of the prior publication. Full disclosure is non-negotiable. Hiding it ends careers.

One more thing on money: if you paid by card and the service was misrepresented, a chargeback is sometimes possible. It rarely works after 90 days, so move fast if you're going to try.

What I'd actually change about how you choose journals

Most people pick a journal at the end, when they're exhausted and want the paper gone. That's exactly when judgment fails, and it's why mills time their emails to land after preprints and conference abstracts appear.

Pick two or three target journals before you write the first draft. Look at where the papers in your own reference list were published — that's your real shortlist, and it's self-verifying, because you already found and trusted those papers. Write to the top one's format. If it's rejected, you've got a second and third ready and you're not making a decision under pressure.

Keeping that shortlist attached to the project rather than in a separate file helps more than it sounds like it should. When I'm working in a connected workspace like PACR for searching and exploring literature, the journals from my reading sit right next to the draft, so by the time I'm writing the cover letter the target list is already there and sourced from papers I actually read. Fewer late-night decisions, fewer regrets. If that's the kind of thing you want from an AI-native research workspace, you can set up a workspace and try it on your current project.

The student who emailed me at 11:40 on a Sunday? She disclosed it to her supervisor, got a partial refund after her university's legal office wrote one letter, and published the extended version of that chapter two years later in a solid specialist journal with full disclosure of the earlier publication. The editor didn't blink.

Next time one of those emails lands in your inbox — and one will — give it the ten minutes before you give it your manuscript.